”After years of research we suddenly realised how to combine our findings. It was a eureka moment.”

Introducing Amferia wound dressing for animal care — binds and kills bacteria without harming the body

How antimicrobial hydrogel can revolutionize clinical treatments

Binds and kills 99.99% of bacteria without harming the body – even resistant bacteria

Introducing Amferia wound dressing for animal care — binds and kills bacteria without harming the body

Antimicrobial dressing:

Amferia has invented a new antimicrobial hydrogel that targets, binds, and rapidly kills up to 99.99% of bacteria upon contact. The hydrogel consists of amphiphilic antibacterial polymers mimicking the immune system. Because the hydrogel binds those polymers in place, nothing is released into the wound, making the dressing safe for the body. 

Amferia is producing a veterinary antimicrobial hydrogel wound dressing, available for order now.

Appropriate for acute and low exuding wounds—such as post-surgical incisions—this product can be used as a free-standing hydrogel pad supported on the wound by a secondary dressing, or as a fully adhesive dressing.

Meant exclusively for veterinary in-clinic use, in places such as surgical care units or in-patient care, all products are supplied sterile and will include instructions for use.  

Read more about the science behind Amferia's products >

Amferia non-adhesive hydrogel dressing

Product description:

Our free-standing hydrogel dressing is currently available for purchase in three standard sizes. The pad is non-adhesive sheet of hydrogel that can be applied directly to a wound bed.

The dressing is non-adhesive to wounds and requires secondary surgical-grade dressing to hold it in place, which Amferia will provide with shipment. Alternatively, customers can use a secondary dressing of their choice. We may also be able to provide custom sizes of the hydrogel pad upon request.

Please contact us with your request >

Easily adaptable to various wounds. Custom sizes available. Can be used with transparent film or absorbent dressings.

  • Hydrogel sizes and product article numbers
  • 1. 4 x 7.5 cm —10085475
  • 2. 4 x 15 cm — 10085415
  • 3. 5 x 20 cm — 10085520
  • We may also be able to provide custom sizes of the hydrogel dressing upon request.

Product Video — How to use the Amferia non-adhesive hydrogel dressing

Amferia adhesive hydrogel dressing

Coming soon:

Amferia's adhesive hydrogel dressing will be available for purchase in 2023. At present, we offer the adhesive dressings on a trial basis for case feedback on dry to low exuding wounds. We are interested in collaborating with clinics that wish to try the products or discuss clinical investigations.

Please contact us to discuss further or request a product specification document >

Evidence of safety and efficacy in post-surgical wounds

Clinical case reports:

Amferia has collaborated with five leading veterinary clinics across Europe and obtained over 100 case reports on a variety of post-surgical wounds of cats and dogs.

In each case, Amferia’s hydrogel dressing enabled safe healing of wounds with no complications. Furthermore, the product could be adapted easily to the complex contours of the animals' bodies and adjusted to the required sizes.

The surgeons who used the dressings have provided excellent feedback on the usability, safety and existing evidence of antimicrobial efficacy.

Infected wounds — killing multi-resistant bacteria

Chronic wounds:

Clinical case reports involving Amferia hydrogel dressings have been performed on infected chronic wounds in collaboration with two clinics in Germany and the Netherlands.

Together with Amferia, the clinics have performed five case evaluations of the Amferia hydrogel dressing in hard-to-heal infected wounds of one dog and four cats, all colonized with multi-resistant pseudomonas aeuruginosa or MRSA bacteria. 

All wounds were open wounds from either trauma or chronic complications, and the patients suffered from recurring wound complications over a period of two to three months. The attending wound specialist requested Amferia dressing for trials on the patients and noted a clear effect within 24 hours, noting bio-burden reduction and formulation of new granulation tissue.

100 times reduction of bacterial load in deep infected wounds

In-vivo study:

Amferia collaborated on an in-vivo infection model study with Chalmers University and the Department of Biomaterials at Sahlgrenska University. 

The study results, published in ACS Biomaterials Science, describe a wound model in mice heavily infected with bacteria. The results demonstrated 100 times reduction of bacterial load in the wounds treated with the amphiphilic antimicrobial hydrogel.  

This is especially impressive, given that the wound was deep and the bacterial load was extremely high. The results demonstrated the strong effect the hydrogel had on bacterial removal, from the wound in a statistically significant manner, without releasing any substances into the body. 


What clinicians say:

  • "It was very easy and fits very well"
  • Dr Christian Ness, Anicura Weingarten
  • "We are very pleased with your product. Can we get an offer?”
  • Dr Ulrich Schmidt, Veterinary clinic Wandsbek
  • "Granulation tissue observed and visible change in bioburden"
  • Dr Peter Engelhardt, Anicura Haan, Germany

How to buy Amferia’s hydrogel wound dressing

Order now:

Amferia Antimicrobial Hydrogel Dressing is now available for purchase in Sweden.

The currently available product for purchase is the free-standing hydrogel dressing, provided in 3 standard sizes. A sheet of hydrogel that can be applied directly to the wound bed and is non-adhesive to wound.

Please contact our Sales Director Saba Atefyekta (PhD) for ordering information >

Collaborate with us and receive samples for trials. Amferia is happy to provide samples of our current and upcoming products for early trials for post-surgical and other dry-to-low exuding wound applications.

Please contact our Product Manager Rojan Modaresi (DVM, PhD) with your interest for product trials >

Amferia raises SEK 6.2 million in pre-seed investment

January 22, 2020

Almi Invest, Chalmers Ventures, along with the British investor Corithinan Properties Ltd. and Let’s Deal Founder Alexander Hars have invested a total of SEK 6.2 million in the Gothenburg-based med-tech company Amferia, who has developed a wound care product with a patented material that actively combats infections and kills antibiotic-resistant bacteria.

“Every year, 700,000 people die globally as a result of infections caused by antibiotic-resistant bacteria and almost half of the infections begin with a simple wound on the skin. Amferia's wound care solution is a game-changer and will save lives”, says Louise Warme, Investment Manager at Almi Invest.

Amferia establishes R&D operations at AstraZeneca’s BioVentureHub

October 28, 2019

Amferia is very excited to move into the BioVentureHub, given the strong benefits of operating in a flourishing environment with state-of-the-art infrastructure dedicated to medtech and life science companies. We are also eager to be around so many experts within life science ranging from established to early-stage companies researching in biopharmaceuticals, medical devices and diagnostics. Amferia looks forward to be part of, learn and grow in this supportive and exciting community.

At the Annual Veterinary Hygiene Conference 2019

October 24, 2019

We had the pleasure to attend the annual Veterinary Hygiene Conference in Knivsta, Stockholm. One of the primary questions of this conference was about handling antibiotic resistant infections in animal wound care – a fast growing problem in Sweden and Globally. Many interesting & enlightening discussions with expert veterinary clinicians taught us a lot about the needs and challenges in animal wound care and how Amferia might expand its innovative solutions to help veterinary healthcare. Thanks for a great conference VVHF.

Amferia wins the Start-up of the Year award at Venture Cup Sweden 2019

September 20, 2019

The Jury's motivation for choosing Amferia as the winners! “With its disruptive solution, the team has the opportunity to shake several industries as they tackle one of humanity’s greatest global threats. By addressing a world problem, millions of lives will be saved. By changing the behavior of the consumer, there is also the potential to reform the market.”

Amferia receives the prestigious EU SME Instrument (Phase 1) grant from the European Union

August 1, 2019

Amferia receives the highly competitive and coveted EU SME Instrument Phase 1 grant of 50 000 Euros along with the valuable business network to take forward our technology into the market.

Amferia presents at Brilliant Minds conference 2019, Stockholm

June 15, 2019

Amferia was honoured to pitch as one of the ‘Next Brilliant in Tech‘ at Brilliant Minds 2019 held at Stockholm between 13-15 June. With esteemed guests like President Barack Obama, Secretary John Kerry, Greta Thunberg, the conference was an enlightening and inspiring event with much hope for the future.

The Recent UN Report on Antibiotic Resistance

May 3, 2019

The United Nations appointed Interagency Coordination Group on Antimicrobial Resistance (IACG) has presented its report on Recommendations to Combat Antimicrobial Resistance (AMR). It is clear from the report that AMR is a global and complex threat that needs to be addressed with extreme urgency and with care. Consistent, coordinated and conscious actions are demanded, especially from the World Goverments, Academia, Public, Healthcare-Industry and  Agriculture. A world where bacterial infections cannot be fought efficiently is a world of perils.

Here is an excerpt from the IACG report.

“The challenges of antimicrobial resistance are complex and multifaceted, but they are not insurmountable. Implementation of the recommendations in this report will help to save millions of lives, preserve antimicrobials for generations to come and secure the future from drug-resistant diseases.

But there is no time to wait.”

-IACG Report, April 29, 2019

Do take a minute and read the summary of this important report (English, pdf 653 kb)

Amferia featured in Göteborgs-Posten

February 8, 2019

New patch from Gothenburg kills bacteria in wounds. Read to know more

Amferia wins the Swedbank Rivstart 2018

February 7, 2019

Amferia is proud to become the winners of the annual entrepreneur competition hosted by Swedbank, Rivstart. From over 1825 applications, Amferia finished on top!

Amferia wins the Venture Day 2018, hosted by Chalmers Ventures

November 28, 2018

Amferia is proud to be named winners of the annual Pitch competition hosted by Chalmers Ventures.